Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility

Cancer Metastasis Rev. 2009 Jun;28(1-2):77-83. doi: 10.1007/s10555-008-9167-2.

Abstract

DLC-1 was originally identified as a potential tumor suppressor. One of the key biochemical functions of DLC-1 is to serve as a GTPase activating protein (GAP) for members of the Rho family of GTPases, particularly Rho A-C and Cdc 42. Since these GTPases are critically involved in regulation of the cytoskeleton and cell migration, it seems clear that DLC-1 will also influence these processes. In this review we examine basic aspects of the actin cyoskeleton and how it relates to cell motility. We then delineate the characteristics of DLC-1 and other members of its family, and describe how they may have multiple effects on the regulation of cell polarity, actin organization, and cell migration.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Movement
  • Cytoskeleton / metabolism*
  • GTPase-Activating Proteins / metabolism*
  • Humans
  • Mice
  • Models, Biological
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Signal Transduction
  • Tumor Suppressor Proteins / metabolism
  • Tumor Suppressor Proteins / physiology*
  • rho GTP-Binding Proteins / metabolism
  • rhoA GTP-Binding Protein / metabolism
  • rhoB GTP-Binding Protein / metabolism
  • rhoC GTP-Binding Protein

Substances

  • DLC1 protein, human
  • GTPase-Activating Proteins
  • Tumor Suppressor Proteins
  • rho GTPase-activating protein
  • RHOA protein, human
  • RHOC protein, human
  • rho GTP-Binding Proteins
  • rhoA GTP-Binding Protein
  • rhoB GTP-Binding Protein
  • rhoC GTP-Binding Protein